These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36653491)

  • 41. Intellectual property. China's innovation landscape.
    Huang KG
    Science; 2010 Aug; 329(5992):632-3. PubMed ID: 20689003
    [No Abstract]   [Full Text] [Related]  

  • 42. Intellectual property and biomedical innovation in the context of Canadian federalism.
    de Beer J; Brusnyk C
    Health Law J; 2011; 19():45-82. PubMed ID: 23185902
    [No Abstract]   [Full Text] [Related]  

  • 43. [The Status of Industry and Supervision of Medical Devices for Human Assisted Reproductive Technology in China].
    Sun X; Han Q
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Nov; 45(6):591-593. PubMed ID: 34862767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of intellectual property rights on health care in Canada.
    Penner MD; Abouali A
    Health Law Can; 2008 Jun; 28(3-4):89-101. PubMed ID: 19051969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 46. Intellectual property. Enhanced: intellectual property landscape of the human genome.
    Jensen K; Murray F
    Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intellectual Property and biodiversity: interplay.
    Bhola R; Dave S
    Pharm Pat Anal; 2017 May; 6(3):105-114. PubMed ID: 28485650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. China steps up US biotech intellectual property land grab.
    Ratner M
    Nat Biotechnol; 2008 Feb; 26(2):141-2. PubMed ID: 18259157
    [No Abstract]   [Full Text] [Related]  

  • 49. Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration.
    Chokshi DA; Parker M; Kwiatkowski DP
    Bull World Health Organ; 2006 May; 84(5):382-7. PubMed ID: 16710548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commercial applicability of cell microancapsulation: a review of intellectual property rights.
    Meier SM
    Adv Exp Med Biol; 2010; 670():137-44. PubMed ID: 20384224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The intellectual property cookbook: a guide for the novice health-care telemedicine provider working with industry.
    Beauregard D; Beauregard G
    J Telemed Telecare; 2000; 6 Suppl 1():S107-9. PubMed ID: 10793990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subsidies versus intellectual property rights when innovators operate in two markets.
    Skliaustyte E; Weber M
    PLoS One; 2023; 18(4):e0284880. PubMed ID: 37093831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pledging intellectual property for COVID-19.
    Contreras JL; Eisen M; Ganz A; Lemley M; Molloy J; Peters DM; Tietze F
    Nat Biotechnol; 2020 Oct; 38(10):1146-1149. PubMed ID: 33020626
    [No Abstract]   [Full Text] [Related]  

  • 54. Learning, technology and intellectual property: a survey of the philosophies and preferences of our trainees and peers.
    Bedoya MA; Back SJ; Scanlon MH; Delgado J; Darge K; Reid JR
    Pediatr Radiol; 2016 Dec; 46(13):1780-1786. PubMed ID: 27543516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Life sciences intellectual property licensing at the Massachusetts Institute of Technology.
    Huang S; Siah KW; Vasileva D; Chen S; Nelsen L; Lo AW
    Nat Biotechnol; 2021 Mar; 39(3):293-301. PubMed ID: 33692518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Short Introduction to Intellectual Property Rights.
    Voss T; Paranjpe AS; Cook TG; Garrison NDW
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):116-120. PubMed ID: 28673648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Function Mechanism of Intellectual Property Capability on Relay Innovation Based on CWLBGSO-DAG-Bootstrap SEM: Mediating Effect of Knowledge Matching and Moderating Effect of Relationship Learning.
    Liu Q; Ding T; Li Y; Gao Z; Guo Y
    Comput Intell Neurosci; 2022; 2022():4357917. PubMed ID: 35800701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 vaccines a global public good? Moving past the rhetoric and making work of sharing intellectual property rights, know-how and technology.
    Meijer M; Verschuuren M; Weggen E
    Eur J Public Health; 2021 Oct; 31(5):925-926. PubMed ID: 34473255
    [No Abstract]   [Full Text] [Related]  

  • 59. Who shall live when not all can live? Intellectual property in accessing and benefit-sharing influenza viruses through the World Health Organisation.
    Lawson C
    J Law Med; 2011 Mar; 18(3):554-76. PubMed ID: 21528740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ECVAM's approach to intellectual property rights in the validation of alternative methods.
    Linge JP; Hartung T
    Altern Lab Anim; 2007 Aug; 35(4):441-6. PubMed ID: 17850189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.